FindTrial
Sign In

Utility of Some Novel Biomarkers of Patients With Chronic Heart Failure

Clinical and Economical Study Evaluating the Utility of Some Novel Biomarkers of Patients With Chronic Heart Failure

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03772275
Enrollment
60
Registered
2018-12-11
Start date
2018-10-01
Completion date
2027-10-31
Last updated
2018-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Brief summary

Clinical and Economic study of some new biomarkers in chronic heart failure.

Detailed description

The study aimed at evaluation of the clinical and economic value of some new biomarkers in chronic heart failure.

Interventions

DIAGNOSTIC_TESTNew york Heart Association Class II-IV

New york Heart Association Class II-IV study of markers

DIAGNOSTIC_TESTNew york Heart Association Class I

New york Heart Association Class I

Sponsors

Sherief Abd-Elsalam
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* NYHA-Class II-IV

Exclusion criteria

* Liver or renal dysfunction. --DM

Design outcomes

Primary

MeasureTime frameDescription
Number of participants with elevated markers (IL17)6 monthsNumber of participants with elevated markers (IL17)

Countries

Egypt

Contacts

Primary ContactSherief Abd-Elsalam, Ph D
sheriefabdelsalam@yahoo.com00201147773440

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026